The outcome of COVID-19 in patients with hematological malignancy

OBJECTIVE: The aim of this study was to examine the effect of coronavirus disease 2019 (COVID-19) on the malignancy-related clinical course and overall survival, and to determine the factors affecting mortality. METHODS: This retrospective study included 77 patients with hematological cancer and COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Tığlıoğlu, Pınar, Albayrak, Murat, Tığlıoğlu, Mesut, Öztürk, Hacer Berna Afacan, Aras, Merih Reis, Sağlam, Buğra, Maral, Senem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655323/
https://www.ncbi.nlm.nih.gov/pubmed/34904019
http://dx.doi.org/10.1007/s12254-021-00775-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655323/
https://www.ncbi.nlm.nih.gov/pubmed/34904019
http://dx.doi.org/10.1007/s12254-021-00775-5

Ejemplares similares